How human IgGs against myelin basic protein (MBP) recognize oligopeptides and MBP

Area of Science:

• Immunology
• Structural Biology
• Neuroscience

Background:

• Myelin basic protein (MBP) is crucial in the pathogenesis of multiple sclerosis.
• The precise mechanisms by which antibodies recognize protein antigens like MBP remain largely uncharacterized.
• Understanding antibody-antigen interactions is vital for autoimmune disease research.

Purpose of the Study:

• To quantitatively analyze the contribution of individual amino acids within an immunodominant MBP sequence to antibody binding.
• To elucidate the recognition mechanism of anti-MBP antibodies in multiple sclerosis patients.
• To develop a thermodynamic model for IgG-MBP interactions.

Main Methods:

• A stepwise increase in ligand complexity using a 12-mer oligopeptide of MBP.
• Analysis of binding affinities of light chains and intact IgGs from multiple sclerosis patients to varying peptide lengths.
• Determination of individual amino acid contributions to antibody binding affinity.

Main Results:

• Free amino acids serve as minimal ligands for IgG light chains, each binding to specific subsites.
• Binding affinity increases additively with peptide length up to six amino acids, then plateaus.
• Intact MBP exhibits significantly higher affinity for IgGs than the specific oligopeptide, engaging both light and heavy chains.

Conclusions:

• This study provides the first quantitative analysis of protein recognition by antibodies.
• The findings reveal a detailed mechanism of how antibodies recognize specific protein sequences.
• The data offer valuable insights for understanding antibody-mediated recognition of various protein antigens.